Cat.#: ACPP-1367
| Despition | Myocilin Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1838 | Human APO D Protein, GST (AC1838) | 2 µg | inquiry |
| ACPP-1445 | Human RAB4A Protein (AC1445) | 2 µg | inquiry |
| ACPP-1579 | Human Leptin Protein, His (AC1579) | 5 µg | inquiry |
| ACPP-1347 | Human HDL Protein (AC1347) | 10 mg | inquiry |
| ACPP-1399 | Human LGALS7 Protein (AC1399) | 2 µg | inquiry |
| ACPP-1489 | Human PSPN Protein (AC1489) | 5 µg | inquiry |
| ACPP-1300 | GTP cyclohydrolase 1 Blocking Peptide (AC1300) | 250 µg | inquiry |
| ACPP-1528 | Human RCAN3 Protein (AC1528) | 2 µg | inquiry |
| ACPP-1486 | Rat VEGF C Protein (AC1486) | 2 µg | inquiry |
| ACPP-1613 | Human RAB3IL1 Protein (AC1613) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.